about
Milnacipran for neuropathic pain and fibromyalgia in adultsFibromyalgia symptoms are reduced by low-dose naltrexone: a pilot studySerotonin-norepinephrine reuptake inhibitors for pain control: premise and promiseJapanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in JapanBiology and therapy of fibromyalgia. New therapies in fibromyalgiaAn integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US.Understanding fibromyalgia: lessons from the broader pain research community.Fibromyalgia: presentation and management with a focus on pharmacological treatment.A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia.Role and rationale for the use of milnacipran in the management of fibromyalgiaInternet-enhanced management of fibromyalgia: a randomized controlled trial.New and emerging therapeutic agents for the treatment of fibromyalgia: an update.Milnacipran for the management of fibromyalgia syndrome.Efficacy of long-term milnacipran treatment in patients meeting different thresholds of clinically relevant pain relief: subgroup analysis of a randomized, double-blind, placebo-controlled withdrawal study.Antidepressants in the treatment of fibromyalgia.Permanent relief from intermittent cold stress-induced fibromyalgia-like abnormal pain by repeated intrathecal administration of antidepressants.Effects of acupuncture on patients with fibromyalgia: study protocol of a multicentre randomized controlled trialPharmacotherapy for fibromyalgia.The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgiaEffects of different antidepressant treatments on the core of depression.Fibromyalgia and depression.Milnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgiaCurrent evidence on atypical odontalgia: diagnosis and clinical managementEffect of Milnacipran on Pain in Patients with Rheumatoid Arthritis with Widespread Pain: A Randomized Blinded Crossover Trial.The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study.Duloxetine: a review of its safety and efficacy in the management of fibromyalgia syndromeA meta-analysis of the efficacy of fibromyalgia treatment according to level of care.Newer treatments for fibromyalgia syndrome.Treatment options and patient perspectives in the management of fibromyalgia: future trends.New treatment options in the management of fibromyalgia: role of pregabalin.Effect of the combined use of tramadol and milnacipran on pain threshold in an animal model of fibromyalgia.Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia.Beyond pain in fibromyalgia: insights into the symptom of fatigue.Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial.Milnacipran inhibits glutamatergic N-methyl-D-aspartate receptor activity in spinal dorsal horn neurons.Alternatives to Opioids in the Pharmacologic Management of Chronic Pain Syndromes: A Narrative Review of Randomized, Controlled, and Blinded Clinical Trials.A Brief Review of the Pharmacology of Amitriptyline and Clinical Outcomes in Treating Fibromyalgia.Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
P2860
Q24201093-523E4C21-DBFA-4F00-9EDE-E406D88D4672Q24630189-62998AC6-527F-4488-8691-9AD1E173EFC2Q24657417-C4C94FB0-EAE4-4029-AAA7-0B9C9598F912Q24658320-D7C80EDC-8D29-43EE-ADB6-F2CE9F4373AFQ24684137-2FB1F982-C371-4351-8C09-E210F186949DQ30236003-017BE5F6-560F-488D-BD51-B7CDCCC7E639Q30480264-8FB6BF9B-532E-4EE3-9027-ED5A8C5D67E1Q33562399-705F1842-54F6-41D1-B787-14455713825DQ33734909-4DF9A810-E103-468C-8AE6-B212AC231247Q33881505-912113D8-BDF5-4BC4-85F2-12BECB4F46A8Q34274158-E2CEA729-12A7-4F7B-9C9F-26C1D92F6048Q34418303-AF60AAE8-E856-4EE2-9442-CB45C212AA2DQ34418392-90A7A663-C63C-44D7-91BF-DEDCC6ED1BD2Q34584386-73168E22-09A6-40E4-898D-18DC9C29933BQ34607230-58266FA8-1A60-49BB-AC66-7351D8429DBCQ34632454-949A4E7C-47DE-4A3E-B168-0D012B8EAF5EQ34662690-A3BE881F-5A28-44FC-8F9A-2A8E2BCDEF8CQ35092347-E2E4D5CF-E160-46DC-BDFB-E6198DA5EF8BQ35092990-83C86FB6-EB0F-4989-98CB-0B63F6DE9D44Q35237015-2AE16659-1AC0-4F6C-9DFD-4AF805299AF0Q35608655-9A14EFF6-E161-4155-9B2A-416AFB18D474Q36059500-1AE24913-12AF-48C9-AEA7-CFC44861E367Q36104428-E4BD2E1A-D768-40C8-BF52-B54BA0CA0A36Q36421939-C0A38FC6-1E8E-48E8-AFCE-C4DC833D0D8FQ36432709-3857E319-ED7D-44F2-A614-2401ABF1A203Q36866408-4C434E3B-7CE4-4436-930C-6F44272D67CCQ36955370-0F7DA5CE-862F-4582-A679-482F98D51ADEQ37098174-FA0DCAB5-4459-4280-B969-37D7F0100CF6Q37106939-B352310E-CA85-419B-ABBD-B55A55963687Q37106971-13C7EE64-B926-47AE-A8C1-066AF48033FDQ37233078-02025838-9B81-49D0-B093-A9E25C9BB8A8Q37478527-CADC0B13-25A7-42B5-93B0-C420855BBA5CQ37690090-E38D5E9E-9FA9-44CF-8D76-A43FA5D4D0A2Q37690346-5814B9CB-BF10-4745-A9E6-0A573E37320BQ41815926-3805B885-6E5E-4FCD-B5B8-91A083D69C11Q43075748-C8D94365-7C04-445E-9C62-F7FF7F3DC82EQ52641632-362379BA-C45F-4D11-B24B-10020D04300FQ52681690-4D76136F-CA6D-468D-9F61-1FB5C738D4FB
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Efficacy of milnacipran in patients with fibromyalgia.
@ast
Efficacy of milnacipran in patients with fibromyalgia.
@en
type
label
Efficacy of milnacipran in patients with fibromyalgia.
@ast
Efficacy of milnacipran in patients with fibromyalgia.
@en
prefLabel
Efficacy of milnacipran in patients with fibromyalgia.
@ast
Efficacy of milnacipran in patients with fibromyalgia.
@en
P2093
P1476
Efficacy of milnacipran in patients with fibromyalgia
@en
P2093
Daniel J Clauw
David A Williams
Jay D Kranzler
Judy F Gendreau
Michael D Thorn
Philip J Mease
R Michael Gendreau
Richard H Gracely
Saulo Ribeiro
P304
P407
P577
2005-10-01T00:00:00Z